ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer

BACKGROUND: The excision repair cross-complementation group 1 (ERCC1) protein is a potential prognostic biomarker of the efficacy of cisplatin-based chemotherapy in non–small-cell lung cancer (NSCLC). Although several ongoing trials are evaluating the level of expression of ERCC1, no consensus has b...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Friboulet, Luc, Olaussen, Ken André, Pignon, Jean-Pierre, Shepherd, Frances A., Tsao, Ming-Sound, Graziano, Stephen, Kratzke, Robert, Douillard, Jean-Yves, Seymour, Lesley, Pirker, Robert, Filipits, Martin, André, Fabrice, Solary, Eric, Ponsonnailles, Florence, Robin, Angélique, Stoclin, Annabelle, Dorvault, Nicolas, Commo, Frédéric, Adam, Julien, Vanhecke, Elsa, Saulnier, Patrick, Thomale, Jürgen, Le Chevalier, Thierry, Dunant, Ariane, Rousseau, Vanessa, Le Teuff, Gwénaël, Brambilla, Elisabeth, Soria, Jean-Charles
Формат: Artigo
Язык:Inglês
Опубликовано: 2013
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4054818/
https://ncbi.nlm.nih.gov/pubmed/23514287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1214271
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы